US stock markets showed mixed but slightly positive performance on April 9, 2025, with the Nasdaq leading, up 1.25%.

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

Pfizer's 7.5% dividend yield, strong R&D innovation, and defensive market position make it a smart buy. Read here for an ...